3M Co (MMM) Shareholder Hyman Charles D Raised Its Stake by $1.04 Million; Fernwood Investment Management Has Increased Stake in Portola Pharmaceuticals Com (PTLA)

December 18, 2017 - By Ellis Scott

Hyman Charles D increased its stake in 3M Co (MMM) by 5.69% based on its latest 2017Q2 regulatory filing with the SEC. Hyman Charles D bought 4,990 shares as the company’s stock rose 7.02% with the market. The institutional investor held 92,638 shares of the medical and dental instruments company at the end of 2017Q2, valued at $19.29 million, up from 87,648 at the end of the previous reported quarter. Hyman Charles D who had been investing in 3M Co for a number of months, seems to be bullish on the $141.76B market cap company. The stock decreased 0.03% or $0.08 during the last trading session, reaching $238. About 4.52 million shares traded or 139.94% up from the average. 3M Company (NYSE:MMM) has risen 18.59% since December 18, 2016 and is uptrending. It has outperformed by 1.89% the S&P500.

Fernwood Investment Management Llc increased its stake in Portola Pharmaceuticals Inc Com (PTLA) by 4.82% based on its latest 2017Q2 regulatory filing with the SEC. Fernwood Investment Management Llc bought 10,975 shares as the company’s stock rose 22.73% with the market. The institutional investor held 238,877 shares of the health care company at the end of 2017Q2, valued at $13.42M, up from 227,902 at the end of the previous reported quarter. Fernwood Investment Management Llc who had been investing in Portola Pharmaceuticals Inc Com for a number of months, seems to be bullish on the $3.07B market cap company. The stock decreased 1.11% or $0.53 during the last trading session, reaching $47.02. About 1.67 million shares traded or 106.81% up from the average. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has risen 51.17% since December 18, 2016 and is uptrending. It has outperformed by 34.47% the S&P500.

Among 15 analysts covering 3M (NYSE:MMM), 7 have Buy rating, 3 Sell and 5 Hold. Therefore 47% are positive. 3M had 69 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Underperform” rating given on Friday, October 23 by RBC Capital Markets. The firm has “Hold” rating given on Wednesday, October 11 by RBC Capital Markets. The firm has “Underweight” rating given on Wednesday, July 26 by Morgan Stanley. The stock of 3M Company (NYSE:MMM) has “Underweight” rating given on Wednesday, March 30 by Morgan Stanley. The rating was maintained by Stifel Nicolaus on Wednesday, December 13 with “Hold”. The firm has “Underperform” rating by RBC Capital Markets given on Wednesday, December 16. The stock has “Buy” rating by Citigroup on Thursday, January 21. Jefferies maintained the stock with “Buy” rating in Thursday, December 14 report. As per Friday, April 28, the company rating was maintained by Barclays Capital. Credit Suisse maintained the stock with “Outperform” rating in Tuesday, March 15 report.

Since August 11, 2017, it had 0 insider buys, and 8 sales for $5.40 million activity. 2,719 3M Company (NYSE:MMM) shares with value of $560,200 were sold by Little Frank R Jr.. THULIN INGE G sold $1.59 million worth of stock or 6,823 shares. Keel Paul A also sold $1.02 million worth of 3M Company (NYSE:MMM) on Friday, August 11. $92,023 worth of 3M Company (NYSE:MMM) shares were sold by Lindekugel Jon T. Gangestad Nicholas C sold 4,004 shares worth $936,291. Shares for $547,377 were sold by Fong Ivan K.

Investors sentiment increased to 0.91 in Q2 2017. Its up 0.10, from 0.81 in 2017Q1. It is positive, as 45 investors sold MMM shares while 589 reduced holdings. 131 funds opened positions while 449 raised stakes. 387.02 million shares or 0.60% more from 384.71 million shares in 2017Q1 were reported. Miller Mgmt L P, a Pennsylvania-based fund reported 9,754 shares. Magnetar Fincl Ltd Liability Corp owns 0.04% invested in 3M Company (NYSE:MMM) for 11,095 shares. M Securities holds 5,450 shares or 0.39% of its portfolio. South Dakota Inv Council holds 0.16% or 35,400 shares in its portfolio. Pictet Asset Ltd holds 0.78% in 3M Company (NYSE:MMM) or 1.23M shares. 150 were reported by Sageworth. Fisher Asset Mngmt Limited Liability holds 0.04% of its portfolio in 3M Company (NYSE:MMM) for 135,983 shares. Mutual Of Omaha Financial Bank Wealth Management has 0.22% invested in 3M Company (NYSE:MMM) for 3,112 shares. Hl Fincl Limited Liability invested 0.75% in 3M Company (NYSE:MMM). United Kingdom-based Hsbc Holding Public Ltd Company has invested 0.43% in 3M Company (NYSE:MMM). 7,257 are held by Maple Inc. Shelton Cap holds 5,434 shares or 0.08% of its portfolio. Nine Masts Limited reported 0.39% stake. California Employees Retirement Systems stated it has 0.49% in 3M Company (NYSE:MMM). Washington Trust Bank & Trust reported 7,014 shares.

Among 6 analysts covering Portola Pharmaceuticals (NASDAQ:PTLA), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Portola Pharmaceuticals had 30 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) earned “Neutral” rating by Credit Suisse on Tuesday, May 31. The stock has “Buy” rating by Citigroup on Wednesday, August 10. The rating was initiated by Goldman Sachs on Friday, December 18 with “Buy”. As per Friday, October 6, the company rating was maintained by Morgan Stanley. Morgan Stanley maintained Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) rating on Friday, August 19. Morgan Stanley has “Overweight” rating and $28 target. The stock of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has “Buy” rating given on Monday, June 26 by Morgan Stanley. The stock has “Neutral” rating by Citigroup on Friday, August 19. The company was initiated on Friday, December 1 by Goldman Sachs. As per Monday, August 28, the company rating was maintained by Oppenheimer. Citigroup maintained Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) on Friday, May 27 with “Buy” rating.

Investors sentiment decreased to 1.31 in 2017 Q2. Its down 0.29, from 1.6 in 2017Q1. It fall, as 17 investors sold PTLA shares while 58 reduced holdings. 45 funds opened positions while 53 raised stakes. 48.64 million shares or 0.79% more from 48.26 million shares in 2017Q1 were reported. Pictet Asset Mngmt Ltd owns 522,237 shares. Alliancebernstein Ltd Partnership has invested 0% of its portfolio in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Perceptive Lc invested in 7,870 shares. Victory Management Inc stated it has 1,265 shares. Farallon Cap Mgmt Limited Liability Corporation invested in 0.5% or 855,000 shares. Bogle Inv Ltd Partnership De invested in 31,851 shares or 0.13% of the stock. Wellington Mngmt Grp Incorporated Ltd Liability Partnership holds 5.65 million shares. Partner Fund Mngmt Ltd Partnership invested in 2.75M shares or 4.15% of the stock. Adage Cap Prns Group Ltd Liability Corp has invested 0.01% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Harvey Cap has 145,755 shares. Metropolitan Life Insurance Company New York, New York-based fund reported 34,415 shares. Hanseatic Service accumulated 22,800 shares. Jane Street Grp Inc Limited Liability has 46,489 shares. Barclays Public Llc accumulated 120,728 shares or 0.01% of the stock. Pub Employees Retirement Association Of Colorado has 0% invested in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) for 12,033 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com